4-(2-Aminopropyl)phenol; Paredrine; 4-Hydroxyamphetamine; Hydroxyamfetamine; Norpholedrine; Oxamphetamine; p-HYDROXYAMPHETAMINE; Norveritol; Oksamfetamin; Oxamfetamin; Oxamphetaminium; Paredrinex; Pulsoton; Nov-Pholedrin; Paradrine; Pedrolon; p-(2-Aminopropyl)phenol; Phenol, 4-(2-aminopropyl)-; Hydroxyamphetamide; 1-p-Hydroxyphenyl-2-propylamine; 2-Amino-1-(p-hydroxyphenyl)propane; Phenol,4-(2-aminopropyl)-; Phenol, p-(2-aminopropyl)-; .alpha.-Methyltyramine; alpha-Methyltyramine; NSC 170995; DL-p-Hydroxyamphetamine; (RS)-4-hydroxyamphetamine; DL-p-(2-Aminopropyl)phenol; 4-Hydroxy-.alpha.-methylphenethylamine; p-Hydroxy-.alpha.-methylphenethylamine; p-Hydroxy-alpha-methylphenethylamine; 4-Hydroxy-alpha-methylphenethylamine; UNII-FQR280JW2N; EINECS 203-152-8; BRN 2413849; Hydroxyamfetamine [INN:BAN]; FQR280JW2N; Predrolon (Salt/Mix); dl-4-hydroxyamphetamine; Spectrum_001243; Spectrum3_001037; Spectrum4_001174; Spectrum5_001674; Hydroxyamphetamine,(+/-); WLN: Z3R DQ; CHEMBL1546; 4-(2-amino-propyl)-phenol; BSPBio_002853; KBioGR_001807; KBioSS_001723; 3-13-00-01709 (Beilstein Handbook Reference); SCHEMBL125440; DTXSID3023134; BDBM81459; CTK4A2457; KBio2_001723; KBio2_004291; KBio2_006859; KBio3_002073; HY-B1098; NSC_3651; 1-(4-Hydroxyphenyl)propane-2-amine; NSC170995; PDSP1_001107; PDSP2_001091; AKOS000155358; AKOS017269170; CS-4687; DB09352; MCULE-6999513658; NE22868; NSC-170995; Phenol, 4-(2-aminopropyl)- (9CI); NCGC00178433-01; NCGC00178433-02; BS-13447; SC-12990; Phenol, p-(2-aminopropyl)-, (.+/-.)-; EN300-53926; Phenol, 4-(2-aminopropyl)-, (.+/-.)-; AB01563354_01; Q5955531; BRD-A80871782-004-01-0; Z57102382